Paricalcitol is a synthetic vitamin D analog that is used in the treatment of chronic kidney disease. However, during the manufacturing process, impurities may be introduced which can impact the safety and efficacy of the drug. The identification and control of these impurities is critical in ensuring the quality of paricalcitol and the safety of patients who rely on it for their health.
